Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Spirometrix Inc.
Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.
- Monitoring Equipment & Devices
In Vitro Diagnostics
- Other Names / Subsidiaries
- Spirosure InC.